The chromosome mutations of CFTR led to cystic fibrosis (CF); interestingly, the existence of a complex of CFTR-NHERF2-lysophosphatidic acids receptor2 in airway and gut epithelium was reported recently, which may provide new therapeutic interventions for CF [31]. This evidence concerns the gene NHERF2 and cystic fibrosis.